AI empowers the development of hematology:Accelerator or disruptor for scientific discovery?OA
A Conversation with Prof.Robert Peter Gale,Editor-in-Chief of Leukemia,on Academic Publishing and International Dissemination 1.Editor’s note In February 2025,we are very pleased to interview Professor Robert Peter Gale,Editor-in-Chief of Leukemia.Prof.Gale has dedicated to scientific and clinical research on leukemia and other bone marrow disorders over 50 years.In this interview,Prof.Gale shared his views on AI technology and its impact on the development of hematology.
Er-liang Wang;Chen Chen
Editorial Office of LabMed Discovery,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,ChinaCenter of International Studies,Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China
医药卫生
scientific discoveryai technologyacceleratorbone marrow disordersdisruptorAIhematologyacademic publishing
《LabMed Discovery》 2025 (1)
P.68-69,2
评论